Tcg Crossover Management, LLC Cogent Biosciences, Inc. Transaction History
Tcg Crossover Management, LLC
- $771 Million
- Q3 2024
A detailed history of Tcg Crossover Management, LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 6,964,375 shares of COGT stock, worth $58.2 Million. This represents 9.76% of its overall portfolio holdings.
Number of Shares
6,964,375
Previous 6,964,375
-0.0%
Holding current value
$58.2 Million
Previous $58.7 Million
28.11%
% of portfolio
9.76%
Previous 8.79%
Shares
7 transactions
Others Institutions Holding COGT
# of Institutions
173Shares Held
114MCall Options Held
56.7KPut Options Held
40.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.5MShares$87.4 Million0.31% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.24MShares$77.2 Million8.19% of portfolio
-
Commodore Capital LP New York, NY7.54MShares$63 Million6.92% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$60.9 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA6.23MShares$52 Million10.93% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $549M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...